Wild Thinking Nick Liddell, Richard Buchanan
2019, 2019-05-03, 2019.
eBook
Who is McLaren's greatest nemesis? What disappoints Ocado about their competitors? What wakes Google up at 4am? Why does Wimbledon sweat the small stuff? Wild Thinking will provide readers with the ...confidence to run their business differently, through unique access to thinking from the most original organizations in business today.The most successful businesses in the world are singular in their goals, yet they express them in many different and creative ways, allowing them to own a space that's distinctly theirs. This book provides access to previously untold stories of how brand leaders at some of the most interesting global businesses solve their biggest challenges.Including interviews with Google, Ocado, McLaren, Comic Relief, V , National Trust, Dropbox and more, each chapter of Wild Thinking explores a different question about life and work, ending with a single-minded point of view to help you consider your business from a new perspective.It's hard to keep up and stand out in constantly growing and changing markets. To succeed you need absolute clarity about what your brand and business offers; it's time to break the rules.
Consumers are hesitant in choosing generic medications as they are under the assumption that they are not as safe nor effective as brand medications. However, pharmacists do have the education and ...training to know that this is not the case. The aim of this study was to determine pharmacists' preference of generic versus brand over-the-counter (OTC) medication for their personal use as self-treatment for various health symptoms.
A prospective, cross sectional study was conducted on 553 licensed pharmacists who were presumed to have expertise in the use of generic and brand name OTC medications. In a single Southwestern state in the United States, from December 2014 to January 2015, a web-based questionnaire was sent to pharmacists to explore their preference of brand and generic medications based on various health symptoms. Thirty-one brand-generic medication pairs were used to identify which medication type pharmacists preferred when asked about nine health symptoms. Frequency counts of pharmacists' preference of a brand medication or a generic OTC medication overall and for each of the nine health symptoms were determined. Chi-squared analyses and one-way ANOVA were conducted to determine if there were any differences between the preferences of brand and generic OTC medications across each symptom.
The study overall showed that pharmacists preferred generic OTC medications to brand OTC medications (62 to 5 %, respectively). Based on an 11-point rating scale, pharmacists were likely to take OTC generic medications (as their choice of self-treatment) when presented with health symptoms (mean = 7.32 ± 2.88). In addition, pharmacists chose generic OTC medications over brand medications regardless of health symptoms (p < 0.001).
Pharmacists who have expertise in medications were shown to prefer using generic OTC medications rather than brand name OTC medications for self-treating a variety of health symptoms. These study findings support the theory that expertise affects preference for generic versus brand name OTC medications. This information can be used to provide consumers the evidence needed to make well-informed choices when choosing between brand and generic medications.
A behavioral process measure was used to investigate the contribution of strategic assets in determining customer perceptions of hotel room price in the Israeli hospitality industry. Participants ...estimated the market price of a single occupancy hotel room after acquiring information on competing hotels. The information available for the competing hotels were price, brand name, star rating, number of rooms, number of restaurants, location and pool size. Prior empirical studies employing a regression analysis on published market data reveal that star rating, brand name, location and number of rooms, are all assets that predict price. Participants selected relatively few information items, with price and star rating information most frequently selected. Brand information was selected more frequently when star information was absent than when it was present suggesting redundancy in the value of the two attributes for market price predictions. Importantly, the performance of middle level hotel managers’ and hotel management university students was indistinguishable on most measures save for initial confidence in their price estimates.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
Slogans are a key element of a brand's identity, and contribute to a brand's equity. In today's marketplace, almost all brands employ slogans; they enhance a brand's image, aid in its recognition and ...recall, and help create brand differentiation in consumers' minds. While there is general consensus on the importance of the device itself, little agreement exists as to what constitutes a successful slogan. As such, although marketing managers use slogans extensively, they are often at a loss when it comes to creating them. In turn, this leads to ineffective use of slogans and, ultimately, the possibility of a surprisingly poor linkage between a brand and its slogan, even among the most well-known brands. To explore this phenomenon, we surveyed articles from a variety of academic streams related to slogans, and also looked at industry publications for relevant case studies. Based on our investigation, we propose in this article a series of guidelines for the strategy behind slogans, and on creation and utilization of effective slogans. In particular, our findings should be of use to business practitioners.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
Background: Generic drugs are manufactured to be similar to their brand name counterparts. They are procured by healthcare organizations and governments to provide accessible and affordable medicines ...for patients worldwide. The objective of this study was to investigate the perception of patients regarding generic drugs. Methods: A non-randomized, cross sectional, convenient sample study design was employed. Patients were interviewed, at selected chronic disease clinics at health institutions in the North Central region of Trinidad, using a questionnaire to garner their perception of generic drugs. Results: While 30.43% of patients knew the names of their prescribed medicines, 74.75% did not know what a generic drug was. After patients were appropriately educated, both the single-item question on perception and the total perception domain demonstrated ‘good’, followed by ‘excellent’ general perception of generic drugs. Conclusion: The use of generic drugs can provide cost-effective, therapeutic benefits to the healthcare sector. Consequently, patient education on the advantages of generic drugs can improve their acceptance.
Full text
Available for:
IZUM, KILJ, NUK, PILJ, PNG, SAZU, UL, UM, UPUK
Desire is big business. If companies can create true desirability for their brands, customers will not only express preference and loyalty, they also show a willingness to act as brand champions, ...participate in online communities, co-create innovative ideas, and show the sort of commitment that is normally associated with fervent employees. However, desire doesn't just happen. Brands need to nurture it by offering both security and surprise. This isn't just about marketing, but rather a reflection of an organization-wide culture and perspective. Using international case studies, Brand Desire explains how companies can engage customers emotionally and create value for them. Managers can successfully build and maintain brand desire through specific strategies and tools, such as: promoting a principles-driven organization that is grounded in its heritage and distinctive competences; creating a supportive culture that encourages the active participation of people in brand development; providing an opportunity for people to communicate more with each other and to encourage socialization through communities and events; and offering outstanding experiences: being consistent in delivery, from first communications through to after-sales service and support. In a crowded sales environment, brand desire can elevate any product or service so that it stands out from the crowd - and stays there. Brand Desire demonstrates how desirable brands are about desirable experiences, and shows what companies can do to maximize those experiences for their customers.
Background: Little is known about how Medicare Part D plan features influence choice of generic versus brand drugs. Objectives: To examine the association between Part D plan features and generic ...medication use. Methods: Data from a 2009 random sample of 1.6 million fee-for-service, Part D enrollees aged 65 years and above, who were not dually eligible or receiving low-income subsidies, were used to examine the association between plan features (generic cost-sharing, difference in brand and generic copay, prior authorization, step therapy) and choice of generic antidepressants, antidiabetics, and statins. Logistic regression models accounting for plan-level clustering were adjusted for sociodemographic and health status. Results: Generic cost-sharing ranged from $0 to $9 for antidepressants and statins, and from $0 to $8 for antidiabetics (across 5th–95th percentiles). Brand-generic cost-sharing differences were smallest for statins (5th–95th percentiles: $16–$37) and largest for antidepressants ($16–$64) across plans. Beneficiaries with higher generic cost-sharing had lower generic use adjusted odds ratio (OR) = 0.97, 95% confidence interval (CI), 0.95–0.98 for antidepressants; OR = 0.97, 95% CI, 0.96–0.98 for antidiabetics; OR = 0.94, 95% CI, 0.92–0.95 for statins. Larger brand-generic cost-sharing differences and prior authorization were significantly associated with greater generic use in all categories. Plans could increase generic use by 5–12 percentage points by reducing generic cost-sharing from the 75th ($7) to 25th percentiles ($4–$5), increasing brand-generic cost-sharing differences from the 25th ($25–$26) to 75th ($32–$33) percentiles, and using prior authorization and step therapy. Conclusions: Cost-sharing features and utilization management tools were significantly associated with generic use in 3 commonly used medication categories.
Full text
Available for:
BFBNIB, CMK, INZLJ, NMLJ, NUK, PNG, UL, UM, UPUK, ZRSKP
A study was designed to recover Listeria monocytogenes from pasteurized milk and Minas frescal cheese (MFC) sampled at retail establishments (REs) and to identify the contamination source(s) of these ...products in the corresponding dairy processing plant. Fifty milk samples (9 brands) and 55 MFC samples (10 brands) were tested from REs located in Juiz de Fora, Minas Gerais, Brazil. All milk samples and 45 samples from 9 of 10 MFC brands tested negative for L. monocytogenes; however, "brand F" of MFC obtained from REs 119 and 159 tested positive. Thus, the farm/plant that produced brand F MFC was sampled; all samples from the milking parlor tested negative for L. monocytogenes, whereas several sites within the processing plant and the MFC samples tested positive. All 344 isolates recovered from retail MFC, plant F MFC, and plant F environmental samples were serotype 1/2a and displayed the same AscI or ApaI fingerprints. Since these results established that the storage coolers served as the contamination source of the MFC, plant F was closed so that corrective renovations could be made. Following renovation, samples from sites that previously tested positive for the pathogen were collected from the processing environment and from MFC on multiple visits; all tested negative for L. monocytogenes. In addition, on subsequent visits to REs 159 and 119, all MFC samples tested negative for the pathogen. Studies are ongoing to quantify the prevalence, levels, and types of L. monocytogenes in MFC and associated processing plants to lessen the likelihood of listeriosis in Brazil.
We aimed to analyse the effects of age and sex on pain and cost for patients with chronic peripheral neuropathic pain (PNP) who have started treatment with brand name gabapentin versus generic ...gabapentin (EFG).
We conducted a retrospective multicentre study using electronic medical records (EMR) for patients of both sexes, older than 18, who began treatment with brand name or generic gabapentin. Adherence (medication possession ratio MPR), persistence, use of healthcare resources, cost, and pain reduction were measured for one year.
We analysed 1369 EMRs 61.1% women; mean age 64.6 (15.9), 52.4%≥65 years; 400 used brand name drugs while 969 used generic gabapentin. Persistence and adherence were higher in patients using brand name gabapentin (7.3 vs 6.3 months, P<.001; 86.5% vs 81.3% MPR, P<.001). Lower healthcare costs were observed in patients using brand-name gabapentin in both age groups (<65 and ≥65). Mean difference in cost per patient amounted to €221 (95%CI: 59-382) and €217 (95%CI: 51-382) in the <65 and ≥65 age groups, respectively (P<.01). Mean difference in cost among men amounted to €197 (63-328), while mean difference in cost among women amounted to €239 (96-397) (P=.005 and P=.004, respectively). Compared with EFG, brand treatment showed greater pain relief: 13.5% (10.9-16.2) and 10.8% (8.2-13.5) in <65 and ≥65year patients, respectively (P<.001), and 10.7% (8.2-13.2) and 13.8% (11.0-16.5) in women and men respectively (P<.001).
Regardless of sex and age, patients who started PNP treatment with brand name medication showed greater persistence and adherence to treatment than those taking generic drugs. Brand name treatment also involved lower healthcare costs, and greater pain relief.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP
PDF
